Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Motor Activity 5Breast Neoplasms 4Urinary Bladder Neoplasms 1Sarcopenia 1Neoplasms 1Lung Neoplasms 1Inflammation 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Cachexia 1

Interventions

Cisplatin 38Carboplatin 28Gemcitabine 23Docetaxel 20Radiotherapy 18Etoposide 15Paclitaxel 13Erlotinib Hydrochloride 13Vinorelbine 11Drug Therapy 11pembrolizumab 9aumolertinib 9apatinib 9Pemetrexed 9Gefitinib 9osimertinib 7endostar protein 7Thoracic Surgery, Video-Assisted 7Blood Specimen Collection 7camrelizumab 6anlotinib 6Vinblastine 6Surgical Procedures, Operative 6sintilimab 5Radiosurgery 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5durvalumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lung Neoplasms × Resistance Training × Clear all
NCT05778136 2023-04-13

Lung Cancer, Exercise and Force Development

Rigshospitalet, Denmark

Phase NA Unknown
20 enrolled
Thoracic

Lung Neoplasms, Motor Activity, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡